Azelaic acid foam 15% + Finacea® (Azelaic acid Foam) 15% + Vehicle of the test product

Phase 1Completed
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Rosacea

Conditions

Rosacea

Trial Timeline

Dec 12, 2017 → Sep 28, 2018

About Azelaic acid foam 15% + Finacea® (Azelaic acid Foam) 15% + Vehicle of the test product

Azelaic acid foam 15% + Finacea® (Azelaic acid Foam) 15% + Vehicle of the test product is a phase 1 stage product being developed by Sun Pharmaceutical for Rosacea. The current trial status is completed. This product is registered under clinical trial identifier NCT03689010. Target conditions include Rosacea.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT03689010Phase 1Completed